Organotin(IV) compounds derived from ibuprofen and cinnamic acids, an alternative into design of anti-inflammatory by the cyclooxygenases (COX-1 and COX-2) pathway

被引:27
|
作者
Romero-Chavez, Maria M. [1 ]
Pineda-Urbina, Kayim [1 ]
Perez, David J. [2 ]
Obledo-Benicio, Fernando [1 ]
Flores-Parra, Angelina [3 ]
Gomez-Sandoval, Zeferino [1 ]
Ramos-Organillo, Angel [1 ]
机构
[1] Univ Colima, Fac Ciencias Quim, Km 9 Carr, Coquimatlan 28400, Colima, Mexico
[2] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2E1, Canada
[3] IPN, Ctr Invest & Estudios Avanzados, Dept Quim, Apartado Postal 14-740, Mexico City 07000, DF, Mexico
关键词
Stannoxanes; Ibuprofen; Coordination; DFT; Docking; Cyclooxygenase; VITRO ANTITUMOR-ACTIVITY; IN-VITRO; CRYSTAL-STRUCTURES; MOLECULAR DOCKING; SPECTROSCOPIC CHARACTERIZATION; DICARBOXYLIC-ACIDS; BASIS-SETS; COMPLEXES; DERIVATIVES; INHIBITORS;
D O I
10.1016/j.jorganchem.2018.02.049
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
New tributyl-, dibutyl-and diphenyl-tin(IV) complexes derived from ibuprofen and cinnamic acids were synthesized. All compounds were structurally characterized by FT-IR, multinuclear H-1, C-13, F-19 and Sn-119 NMR and corroborated by 2D spectra. The NMR data in CDCl3 revealed several hexacoordinated compounds with octahedral geometry. Moreover, in DMSO-d(6) some of these complexes switched to heptacoordination with a pentagonal-bipyramidal geometry due to the inclusion of a solvent's molecule; their Sn-119 signals moved up field by around 58 ppm compared to their chemical shifts in non-coordinated solvent CDCl3. The structural results were supported by Density Functional Theory (DFT) computational calculations. In addition, a docking study was performed to evaluate the ability of ligands to interact within the active site of cyclooxygenases (COX-1 and COX-2). Docking results showed a possible binding of stannoxanes theoretically more selective towards COX-2 than ibuprofen. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:58 / 70
页数:13
相关论文
共 50 条
  • [41] Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis
    Tanaka, Ken-Ichiro
    Suemasu, Shintaro
    Ishihara, Tomoaki
    Tasaka, Yuichi
    Arai, Yasuhiro
    Mizushima, Tohru
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 603 (1-3) : 120 - 132
  • [42] Design and synthesis of novel quinazolinones conjugated ibuprofen, indole acetamide, or thioacetohydrazide as selective COX-2 inhibitors: anti-inflammatory, analgesic and anticancer activities
    Sakr, Asmaa
    Rezq, Samar
    Ibrahim, Samy M.
    Soliman, Eman
    Baraka, Mohamed M.
    Romero, Damian G.
    Kothayer, Hend
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 1810 - 1828
  • [43] Quantification of Marker Compound by HPTLC-densitometry Method and Assessment of Anti-inflammatory Activity of Root-bark Extract of Berberis aristata with Molecular Docking by COX-1 and COX-2
    SHRIVASTAV, A. L. A. N. K. A. R.
    MISHRA, A. R. U. N. K. U. M. A. R.
    GUPTA, A. S. H. E. E. S. H. K. U. M. A. R.
    ORIENTAL JOURNAL OF CHEMISTRY, 2022, 38 (02) : 302 - 311
  • [44] Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibition activities and molecular docking study of pyrazoline derivatives
    Abdel-Sayed, Maged A.
    Bayomi, Said M.
    El-Sherbeny, Magda A.
    Abdel-Aziz, Naglaa I.
    ElTahir, Kamal Eldin H.
    Shehatou, George S. G.
    Abdel-Aziz, Alaa A. -M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (09) : 2032 - 2042
  • [45] New non steroidal anti-inflammatory drugs: NO-releasing compounds and selective COX-2 inhibitors.
    Bannwarth, B
    Berenbaum, F
    REVUE DE MEDECINE INTERNE, 1999, 20 : 341S - 345S
  • [46] Molecular docking investigation of anti-inflammatory herbal compounds as potentia LOX-5 and COX-2 inhibitors
    Vyshnevska, Liliia
    Severina, Hanna, I
    Prokopenko, Yuliya
    Shmalko, Alexander
    PHARMACIA, 2022, 69 (03) : 733 - 744
  • [47] Anti-inflammatory and antioxidant potential of Guaianolide isolated from Cyathocline purpurea: Role of COX-2 inhibition
    Tambewagh, Urmila U.
    Kandhare, Amit D.
    Honmore, Varsha S.
    Kadam, Parag P.
    Khedkar, Vijay M.
    Bodhankar, Subhash L.
    Rojatkar, Supada R.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 52 : 110 - 118
  • [48] Design and synthesis of anti-inflammatory 1,2,3-triazolylpyrrolobenzodiazepinone derivatives and impact of molecular structure on COX-2 selective targeting
    Kumar, Amit
    Alam, Mohammad Sarwar
    Hamid, Hinna
    Chugh, Vaishali
    Tikla, Tanvi
    Kaul, Rajeev
    Dhulap, Abhijeet
    Sharma, Sunil K.
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1272
  • [49] Design, synthesis of novel isoindoline hybrids as COX-2 inhibitors: Anti-inflammatory, analgesic activities and docking study
    Labib, Madlen B.
    Sharkawi, Souty M. Z.
    El-Daly, Mahmoud
    BIOORGANIC CHEMISTRY, 2018, 80 : 70 - 80
  • [50] tNOX, an alternative target to COX-2 to explain the anticancer activities of non-steroidal anti-inflammatory drugs (NSAIDS)
    D. James Morré
    Dorothy M. Morre
    Molecular and Cellular Biochemistry, 2006, 283 : 159 - 167